Research

Life Sciences & Biotechnology

Title :

To enhance the therapeutic efficase of Doxorubicin by targeting Hypoxia inducible factor 1a and 2a through Selenium nano particles in hepatocellular carcinoma cells

Area of Research :

Life Sciences & Biotechnology, Medical Sciences

Focus Area :

Hepatocellular carcinoma cells

Principal Investigator :

Dr. C. Thirunavukkarasu, Assistant Professor, Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry

Contact info :

Timeline Start Year :

2016

Total Budget (INR):

 10,58,000

Details

Organizations involved

Implementing Agency :

Department of Biochemistry and Molecular Biology, Pondicherry University, Puducherry

Funding Agency :

Science and Engineering Research Board (SERB), Department of Science & Technology (DST), Govt. of India

Related Research

Exosomes as therapeutic drug carriers and delivery vehicle development for import substitution
To investigate the relevance of Tumor necrosis factor like weak inducer of apoptosis (TWEAK) as a novel therapeutic target and clinical severity marker in Chronic Obstructive Pulmonary Disorder (COPD) and associated pulmonary hypertension
Integrated approach for chitinase production from marine resources for synthesis of bio-active chitooligosaccharides and developing a nano system as potent anti-phytopathogen
Alteration of Ethylene signaling Pathway in Tomato for Geminivirus Tolerance
Urine Tract Infections and Antimicrobial susceptibility - A fight against Superbugs